Intellia Therapeutics
@intelliatx
Followers
12K
Following
164
Media
850
Statuses
1K
We're a #GeneEditing company, developing novel, potentially curative therapeutics leveraging #CRISPR-based technologies. Guidelines: https://t.co/u2gHl9Tmgr
Cambridge, MA
Joined July 2014
#ATTR News: Intellia presents positive longer-term follow-up data from its ongoing Phase 1 trial in ATTR #amyloidosis with cardiomyopathy at the American Heart Association Scientific Sessions (@American_Heart). Full details here: https://t.co/69KCj1HMBy
6
18
58
#HAE News: Intellia presents positive follow-up data from its ongoing Phase 1/2 trial in #hereditaryangioedema at the American College of Allergy, Asthma and Immunology Scientific Meeting (@ACAAI). Read the press release: https://t.co/ld9PDVIomt
2
8
45
Today is #WorldAmyloidosisDay, a global event dedicated to raising awareness of #ATTR #amyloidosis. This day is close to our heart, and we are humbled to have a hand in this journey. Over the past couple of weeks, we wrote down some of our biggest and boldest dreams of what the
4
4
26
Today is the start of the @AmyloidASG National Meeting in Chicago. Several members from our #ATTR team will be in attendance and at our booth. We are looking forward to the great conversations ahead!
1
3
25
It’s #WorldCRISPRDay, a time to recognize the potential of #CRISPR and how far science has come. 🧬 But first – what is CRISPR? Here, we explain how it works as a form of #geneediting, a technique Intellia is investigating in our effort to address rare diseases. Read more:
1
7
40
This weekend, our team will be at the 2025 @HAE Regional Conference EMEA in Rome, Italy. We look forward to gathering insights from the #HAE patient community and physicians. https://t.co/vcR5kCeW7q
2
3
16
🔴 📣 Watch this month’s new US HAEA Treatment Education Series Webinar: “Living with HAE: Insights and the HAE Community Survey.” Now on-demand! Watch here: https://t.co/JtnXwNQGAg
#HAEA #HAEAwareness #HAEATreatmentSeries #HereditaryAngioedema #HAECommunity
1
5
10
Members from Intellia’s team will be at the @HFSA Annual Scientific Meeting this weekend in Minneapolis. We look forward to connecting and the insightful conversations!
0
3
15
$NTLA News: Intellia announces positive longer-term data from the ongoing Phase 1 trial in #ATTRamyloidosis with polyneuropathy and the company’s latest publication in @NEJM. Read the press release: https://t.co/T94tQhVdEN
2
9
47
The Intellia team is gearing up for the 5th International #ATTR #Amyloidosis Meeting for Patients and Doctors in Baveno, Italy, Sept. 25-26. Press Release: https://t.co/9kzvaYLyBG HCPs: Be sure to tune into our presentation on Thursday and stop by our booth to learn even more
1
4
24
$NTLA News: We’re excited to share Intellia has completed enrollment in HAELO, our Phase 3 trial for the treatment of #hereditaryangioedema. Read the press release: https://t.co/KLrvA4Phik
5
17
90
Later today, Intellia’s SVP, Technical Operations, Kristy Wood, Ph.D., will be delivering a keynote at Cell & Gene Therapy International: From Breakthrough Science to Life-Changing Treatments in Boston. #CGTI
@CellTherapyIC
1
2
15
Unpredictable. Mentally exhausting. These are some of the words used to describe a day in the life as someone living with #hereditaryangioedema. Through our research, we’ve learned people living with #HAE face daily challenges – physical or emotional. At Intellia, our mission
2
4
31
Starting tomorrow, members from Intellia’s management team will be heading to two investor conferences this month: > @WellsFargo Healthcare Conference – Boston > Bernstein Healthcare Forum – New York We look forward to connecting and sharing Intellia’s progress.
2
4
25
This weekend, members from our #ATTR team will be at the #ESCCongress. HCPs: Don’t miss our symposium on Monday, chaired by Dr. Julian Gillmore, discussing all things #amyloidosis and advancements in the field. #ESCCongress #WCCardio
0
6
18
Intellia is committed to fostering relationships with patient advocacy organizations to gain a comprehensive understanding of various conditions and its impact on patients and their families. Today, we share a glimpse into what life can look like for those living with
1
2
33
As part of our efforts to bring Intellia’s promising therapies to those in need, we’ve been building out our commercial and medical functions. They each play a pivotal role in shaping our strategy and advancing our mission. Hear what some of our leaders have to say. #OneIntellia
2
2
25